Syngene International, a contract research arm of biotechnology major Biocon, is planning to set up a new manufacturing plant in Mangalore SEZ entailing an investment of about $100 million amounting over Rs 660 crore. The company is in the process of acquiring 40 acres of land and obtaining necessary approvals for the same.
Syngene International offers discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 424.15 |
| Indegene | 490.60 |
| CMS Info Systems | 309.60 |
| JITF Infralogistics | 312.00 |
| Sagility | 41.84 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: